Kim Hae Jin, Yoo So-Young, Jeon Tae Yeon, Kim Ji Hye
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Clin Imaging. 2016 Sep-Oct;40(5):1018-22. doi: 10.1016/j.clinimag.2016.06.006. Epub 2016 Jun 16.
To evaluate image quality and dose reduction of ultra-low-dose pediatric chest CT reconstructed with model-based iterative reconstruction (MBIR), as compared with adaptive statistical iterative reconstruction (ASIR).
Fifty-seven patients (mean age 14 years, M:F=31:26) who underwent ultra-low-dose chest CT reconstructed with both MBIR and ASIR were enrolled in the study. The subjective and objective image qualities of both reconstruction techniques were assessed by 3 radiologists, and compared using statistical analysis. We also evaluated radiation dose of ultra-low-dose chest CT as well as degree of dose reduction in comparison to the prior CT (either standard dose or reduced dose protocol) available in 36 patients.
The image quality of MBIR was superior to ASIR both subjectively and objectively. While MBIR showed preserved diagnostic acceptability in 100%, ASIR showed 92% at mean 0.31 mSv (range, 0.13-0.57 mSv) ultra-low-dose CT. In the 36 patients who underwent the prior CT, mean decrease in size-specific dose estimate (SSDE) and dose length product (DLP) at ultra-low-dose CT was 88% (range, 34% - 98%) and 86% (range,42% - 99%), respectively.
MBIR significantly improves image quality, as compared to ASIR. Furthermore, MBIR facilitates diagnostically acceptable ultra-low-dose chest CT with nearly 90% less radiation.
与自适应统计迭代重建(ASIR)相比,评估基于模型的迭代重建(MBIR)重建的超低剂量儿科胸部CT的图像质量和剂量降低情况。
本研究纳入了57例接受了MBIR和ASIR重建的超低剂量胸部CT的患者(平均年龄14岁,男:女 = 31:26)。由3名放射科医生评估两种重建技术的主观和客观图像质量,并进行统计分析比较。我们还评估了超低剂量胸部CT的辐射剂量以及与36例患者可用的先前CT(标准剂量或降低剂量方案)相比的剂量降低程度。
MBIR的图像质量在主观和客观上均优于ASIR。在平均0.31 mSv(范围0.13 - 0.57 mSv)的超低剂量CT中,MBIR的诊断可接受性为100%,而ASIR为92%。在接受先前CT检查的36例患者中,超低剂量CT时特定尺寸剂量估计(SSDE)和剂量长度乘积(DLP)的平均降低分别为88%(范围34% - 98%)和86%(范围42% - 99%)。
与ASIR相比,MBIR显著提高了图像质量。此外,MBIR有助于实现诊断可接受的超低剂量胸部CT,辐射剂量减少近90%。